FI951594A0 - Uudet farmauttiset spiramysiiniseokset - Google Patents

Uudet farmauttiset spiramysiiniseokset

Info

Publication number
FI951594A0
FI951594A0 FI951594A FI951594A FI951594A0 FI 951594 A0 FI951594 A0 FI 951594A0 FI 951594 A FI951594 A FI 951594A FI 951594 A FI951594 A FI 951594A FI 951594 A0 FI951594 A0 FI 951594A0
Authority
FI
Finland
Prior art keywords
spiramycin
mixtures
new pharmaceutical
formulations
new
Prior art date
Application number
FI951594A
Other languages
English (en)
Swedish (sv)
Other versions
FI951594A (fi
Inventor
Francois-Xavier Piot
Robert Rona
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI951594A0 publication Critical patent/FI951594A0/fi
Publication of FI951594A publication Critical patent/FI951594A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI951594A 1992-10-05 1995-04-04 Uudet farmauttiset spiramysiiniseokset FI951594A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9211747A FR2696346B1 (fr) 1992-10-05 1992-10-05 Nouvelles formulations pharmaceutiques de spiramycine.
PCT/FR1993/000945 WO1994007504A1 (fr) 1992-10-05 1993-09-28 Nouvelles formulations pharmaceutiques de spiramycine
US08/470,319 US5696095A (en) 1992-10-05 1995-06-06 Pharmaceutical formulations of spiramycin

Publications (2)

Publication Number Publication Date
FI951594A0 true FI951594A0 (fi) 1995-04-04
FI951594A FI951594A (fi) 1995-04-04

Family

ID=26229777

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951594A FI951594A (fi) 1992-10-05 1995-04-04 Uudet farmauttiset spiramysiiniseokset

Country Status (13)

Country Link
US (1) US5696095A (fi)
EP (1) EP0662835B1 (fi)
JP (1) JPH08501785A (fi)
AT (1) ATE145555T1 (fi)
CA (1) CA2146251A1 (fi)
DE (1) DE69306263T2 (fi)
DK (1) DK0662835T3 (fi)
ES (1) ES2094566T3 (fi)
FI (1) FI951594A (fi)
FR (1) FR2696346B1 (fi)
GR (1) GR3021788T3 (fi)
HU (1) HU214825B (fi)
WO (1) WO1994007504A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
FR2817751A1 (fr) * 2000-12-07 2002-06-14 Maximun Frederic Yanze Nouvelles compositions pharmaceutiques de sirops et sirops secs contenant de la quinine
EP2201939A1 (en) 2008-12-25 2010-06-30 Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. Method for producing coated spiramycin and novel formulations containing the same
GB2543417B (en) 2015-09-11 2017-10-18 Guise Andrew An oral particulate composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
IT1229568B (it) * 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
ES2017559A6 (es) * 1989-10-04 1991-02-16 Rhone Poulenc Farma Sa Procedimiento para la formulacion de la espiramicina.
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
FR2669533B1 (fr) * 1990-11-26 1993-01-08 Rhone Poulenc Rorer Sa Procede de preparation de formulations de spiramycine et formulations orales de spiramycine.

Also Published As

Publication number Publication date
JPH08501785A (ja) 1996-02-27
US5696095A (en) 1997-12-09
FR2696346A1 (fr) 1994-04-08
ES2094566T3 (es) 1997-01-16
EP0662835B1 (fr) 1996-11-27
CA2146251A1 (fr) 1994-04-14
HU9500972D0 (en) 1995-06-28
FR2696346B1 (fr) 1994-11-25
DK0662835T3 (da) 1996-12-16
HU214825B (hu) 1998-06-29
DE69306263D1 (de) 1997-01-09
EP0662835A1 (fr) 1995-07-19
GR3021788T3 (en) 1997-02-28
HUT71555A (en) 1995-12-28
ATE145555T1 (de) 1996-12-15
FI951594A (fi) 1995-04-04
DE69306263T2 (de) 1997-04-17
WO1994007504A1 (fr) 1994-04-14

Similar Documents

Publication Publication Date Title
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69932835D1 (de) Medizinische aerosolzubereitung
PT1121144E (pt) Preparados de insulina concentrada estavel para administracao pulmonar
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
DK678887D0 (da) Farmaceutiske praeparater
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO910213L (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
ATE110071T1 (de) Pyridazinon-derivate und diese enthaltende pharmazeutische zubereitungen.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
DK0539479T3 (da) Heterocykliske forbindelser
NO871044D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
SE8704952L (sv) Farmaceutisk komposition
FI951594A0 (fi) Uudet farmauttiset spiramysiiniseokset
EP0261524A3 (de) Arzneimittelzubereitungen
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks

Legal Events

Date Code Title Description
FD Application lapsed